Products found to contain undeclared medicines
|
| |
| The United States : TF Supplements Issues Voluntary Nationwide Recall of All Lots of Rhino 7 3000 and Rhino 7 Platinum 3000 Capsules due to Undeclared Active Pharmaceutical Ingredients |
| |
TF Supplements of Houston, TX, is voluntarily recalling the following product to the consumer level: RHINO 7 3000 capsules packaged in a bottle containing six (6) capsules UPC: 616453150126 ALL LOT NUMBERS WITHIN EXPIRY and Rhino 7 Platinum 3000 Capsules packaged in a single (1) blister packs hang card count UPC: 700729253748 ALL LOT NUMBERS WITHIN EXPIRY. Lot numbers are on the back top right of the (1) count and on the side of the (6) count bottle. The U.S. Food and Drug Administration (FDA) analysis found these products to contain undeclared desmethyl carbondenafil and dapoxetine. Desmethyl carbondenafil is a phosphodiesterase PDE-5 inhibitor which is a class of drugs used to treat male erectile dysfunction, making these products unapproved new drugs. Dapoxetine is an active ingredient not approved by FDA.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these products.
Please refer to the following website in US FDA for details:
http://www.fda.gov/Safety/Recalls/ucm466502.htm
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/ Saturday, Oct 10, 2015
Issued at HKT 12:00
|
| |
|
